Use of proton pump inhibitors and increased risk of fracture in type 2 DM and menopausal women: a systematic review and meta-analysis
African Health Sciences · 2026 · 26 (1) · 134-150
DOI: 10.4314/ahs.v26i1.15 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift African Health Sciences, 2026. Verfasst von Pradeep Battula und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Santhiram College of Pharmacy, Nandyal, Andhra Pradesh, India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Proton Pump Inhibitors, Fractures, Bone, Postmenopause. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To investigate the relationship between type 2 diabetes mellitus and postmenopausal women with fracture risk when using PPIs.
Methods
We conducted an observational study to investigate the association between PPI use and an increased fracture risk in postmenopausal women and type 2 diabetes mellitus. We searched for epidemiological studies published between 2006 and 2023 in PubMed, Google Scholar, and other bibliographies of the retrieved papers. The pooled OR was obtained using the random-effects model, and a subgroup analysis was conducted.
Results
Eight studies, including six cohorts and two case-control studies, were conducted with 1.3 million participants. In these studies, 1,63,346 cases of fracture risk were identified. The pooled effect estimate of these studies was OR 1.61, with a 95% CI of 1.36-1.90. This indicates a significant correlation between Type 2 diabetes mellitus, post-menopausal women, and the risk of fractures. The OR for type 2 DM alone was 1.34 (95% CI 1.14-1.57), and for menopausal women alone, the OR was 2.15 (95% CI 1.36-1.90). Notably, there was no evidence of publication bias.
Conclusion
This meta-analysis provides strong evidence that PPI use in type 2 DM and menopausal women is significantly associated with the risk of developing fractures. Keywords: Elderly patients; Proton pump inhibitors; Postmenopausal women; Type 2 diabetes mellitus; Risk of fractures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, Santhiram College of Pharmacy, Nandyal, Andhra Pradesh, India.
- Department of Surgical Gastroenterology, Santhiram medical college and General Hospital, Nandyal, Andhra Pradesh, India.
- Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER) Guwahati, Assam, India.
Zitieren
APA
Battula, P., Sree, P. B., Latha, Y. S., Poojitha, K. N., Reddy, K. V. S., Krishna, S. S. V., Sri Charan, P. R., & Undela, K. (2026). Use of proton pump inhibitors and increased risk of fracture in type 2 DM and menopausal women: a systematic review and meta-analysis. African Health Sciences, 26(1), 134-150. https://doi.org/10.4314/ahs.v26i1.15
Vancouver
Battula P, Sree PB, Latha YS, Poojitha KN, Reddy KVS, Krishna SSV, et al. Use of proton pump inhibitors and increased risk of fracture in type 2 DM and menopausal women: a systematic review and meta-analysis. African Health Sciences. 2026;26(1):134-150. doi:10.4314/ahs.v26i1.15
BibTeX
@article{Battula2026,
author = {Battula, Pradeep and Sree, Poli Bhuvana and Latha, Yapareddygari Sandhya and Poojitha, Kotha Naga and Reddy, Kamini Venkata Subba and Krishna, Setlem Sai Venkata and Sri Charan, P Raghu and Undela, Krishna},
title = {Use of proton pump inhibitors and increased risk of fracture in type 2 DM and menopausal women: a systematic review and meta-analysis},
journal = {African Health Sciences},
year = {2026},
volume = {26},
number = {1},
pages = {134--150},
doi = {10.4314/ahs.v26i1.15}
}
EUVIMED